HOME >> BIOLOGY >> NEWS
Young scientists awarded for achievements in cancer research

To maintain the flow of keen minds into the research talent pool, the American Association for Cancer Research is holding two special programs for young scientists at this year's Annual Meeting: the AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students, and the AACR Special Program for High School Students. The meeting will be held at the Orange County Convention Center in Orlando, March 27-31, 2004.

The programs give students an excellent opportunity to gain exposure to the professional world of cancer research and biomedicine. The AACR Science Education Committee organizes both.

Twenty undergraduate students will receive AACR-Thomas J. Bardos Science Education Awards. Dr. Bardos, a native of Hungary, came to the United States after World War II to earn a Ph.D. in chemistry from the University of Notre Dame. He went on to hold a full professorship at the State University of New York at Buffalo, where he was a member of the faculty until his retirement in 1995 and still holds emeritus status. He has been a member of the AACR for 45 years and has supported the Science Education Awards for college students since 1997.

Thanks to Dr. Bardos' support and dedication to the future of cancer research, recipients of the award receive financial support to attend two consecutive Annual Meetings. His contributions are matched by the AACR.

To qualify for the award, candidates must be full-time, third-year undergraduates majoring in science. There are 10 winners for 2003-2004, as well as the 10 winners from 2004-2005 who will be attending their second AACR Annual Meeting. The names and affiliations of the recipients are as listed below, in alphabetical order by state.

2004-2005 AACR-Thomas J. Bardos Science Education Awardees

2003-2004 AACR-Thomas J. Bardos Science Education Awardees

Winners will be made Student Members of the AACR.

Under the aus
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
16-Mar-2004


Page: 1 2

Related biology news :

1. Second call for proposals for the European Young Investigator Award
2. Kiratisin wins 2004 Dade MicroScan Young Investigator Award
3. APS announces four 2004 Young Investigators awards
4. Young chimpanzees show sex differences in learning
5. A big surprise: Young nerve cells can rewind their developmental clocks
6. Young cancer researchers honored
7. Young sea animals clone themselvescentury-old debate halted
8. EMBO Young Investigators 2000 2002
9. Young plants natural defenses amount to more than just its seed
10. UT Southwestern postdoctoral researcher wins international Young Scientist Prize
11. APS announces its 2002 Young Investigators Awards

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Young scientists awarded for achievements cancer research

(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/30/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ... Gesture Recognition Market in Automotive Sector 2014-2018" report ... Global Gesture Recognition market in Automotive Sector to grow ... Gesture recognition is the ability of a ... an individual. Gesture recognition technology can be 2D-based or ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
(Date:3/31/2015)... Diasome Pharmaceuticals, Inc. ( http://www.diasome.com ) has ... United States patent has recently been allowed for the ... Entitled “Lipid Construct for Delivery of Insulin to a ... to the use of Diasome’s proprietary Hepatocyte Directed Vesicles ... more effectively reach the liver’s metabolic cells, called hepatocytes. ...
(Date:3/30/2015)... NC (PRWEB) March 30, 2015 ... are pleased to announce the formation of VaxCorps, ... research centers specializing in the conduct of vaccine ... VaxCorps clinical sites have successfully conducted over ... experience in seasonal and pandemic influenza as well ...
(Date:3/30/2015)... March 30, 2015  NuGene International, Inc. ("NuGene") ... NuGene BioPharma, Inc. has added another internationally recognized ... Guan is an internationally recognized researcher in bio-inspired ... education at Peking University, China ... the University of North Carolina, Chapel Hill. Following ...
(Date:3/30/2015)... March 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a commercial focus on China ... Administration (CFDA) has approved the Company,s application to conduct ... cell carcinoma (OCCC) patients for its proprietary drug candidate ...
Breaking Biology Technology:Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5
Cached News: